FDA approves treatment for rare cancer
Monday, November 9, 2009 - 16:56
in Health & Medicine
WASHINGTON, Nov. 9 (UPI) -- The U.S. Food and Drug Administration says it has approved a new treatment for patients with a rare form of cancer known as Cutaneous T-cell Lymphoma.
Read the whole article on UPI
More from UPI
Related
- Approved lymphoma drug shows promise in early tests against bone cancerThu, 5 Nov 2009, 11:53:38 EST
- Every patient is unique: Individualized therapies for non-Hodgkin's lymphomaThu, 19 Jun 2008, 6:49:52 EDT
- FDA approved leukemia drugs shows promise in ovarian cancer cellsTue, 10 Nov 2009, 9:09:38 EST
- Two targeted therapies likely better than one in patients with aggressive lymphomaFri, 15 May 2009, 9:16:39 EDT
- ICT fails to accelerate drug approvalsThu, 19 Nov 2009, 9:58:09 EST